These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 37358084)
1. Sufentanil inhibits the metastasis and immune response of breast cancer via mediating the NF-κB pathway. Li M; Gu K; Kong Q; Wang G; Gu J Immunopharmacol Immunotoxicol; 2023 Dec; 45(6):663-671. PubMed ID: 37358084 [TBL] [Abstract][Full Text] [Related]
2. Sufentanil combined with parecoxib sodium inhibits proliferation and metastasis of HER2-positive breast cancer cells and regulates epithelial-mesenchymal transition. Xu S; Li X; Li W; Ma N; Ma H; Cui J; You X; Chen X Clin Exp Metastasis; 2023 Apr; 40(2):149-160. PubMed ID: 36807216 [TBL] [Abstract][Full Text] [Related]
3. Oroxylin A Suppresses the Cell Proliferation, Migration, and EMT via NF- Sun X; Chang X; Wang Y; Xu B; Cao X Biomed Res Int; 2019; 2019():9241769. PubMed ID: 31341911 [TBL] [Abstract][Full Text] [Related]
4. Activation of lncRNA lnc-SLC4A1-1 induced by H3K27 acetylation promotes the development of breast cancer via activating CXCL8 and NF-kB pathway. Yi T; Zhou X; Sang K; Huang X; Zhou J; Ge L Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3765-3773. PubMed ID: 31556319 [TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA NKILA inhibited angiogenesis of breast cancer through NF-κB/IL-6 signaling pathway. Luo LH; Rao L; Luo LF; Chen K; Ran RZ; Liu XL Microvasc Res; 2020 May; 129():103968. PubMed ID: 31862380 [TBL] [Abstract][Full Text] [Related]
6. Activation of NF-κB by the RANKL/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell lines. Tsubaki M; Komai M; Fujimoto S; Itoh T; Imano M; Sakamoto K; Shimaoka H; Takeda T; Ogawa N; Mashimo K; Fujiwara D; Mukai J; Sakaguchi K; Satou T; Nishida S J Exp Clin Cancer Res; 2013 Sep; 32(1):62. PubMed ID: 24011086 [TBL] [Abstract][Full Text] [Related]
7. Nuclear receptor binding SET domain protein 1 promotes epithelial-mesenchymal transition in paclitaxel-resistant breast cancer cells via regulating nuclear factor kappa B and F-box and leucine-rich repeat protein 11. Chen Y; Tang W; Zhu X; Zhang L; Zhu Y; Xiao H; Xu J; Fang Y; Li X; Tang C; Shi J Bioengineered; 2021 Dec; 12(2):11506-11519. PubMed ID: 34905470 [TBL] [Abstract][Full Text] [Related]
8. Sinomenine inhibits breast cancer cell invasion and migration by suppressing NF-κB activation mediated by IL-4/miR-324-5p/CUEDC2 axis. Song L; Liu D; Zhao Y; He J; Kang H; Dai Z; Wang X; Zhang S; Zan Y Biochem Biophys Res Commun; 2015 Aug; 464(3):705-10. PubMed ID: 26166821 [TBL] [Abstract][Full Text] [Related]
9. Midkine promotes breast cancer cell proliferation and migration by upregulating NR3C1 expression and activating the NF-κB pathway. Zhang L; Song L; Xu Y; Xu Y; Zheng M; Zhang P; Wang Q Mol Biol Rep; 2022 Apr; 49(4):2953-2961. PubMed ID: 35028860 [TBL] [Abstract][Full Text] [Related]
10. Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways. Esparza-López J; Alvarado-Muñoz JF; Escobar-Arriaga E; Ulloa-Aguirre A; de Jesús Ibarra-Sánchez M BMC Cancer; 2019 Jul; 19(1):728. PubMed ID: 31337349 [TBL] [Abstract][Full Text] [Related]
11. Gemifloxacin inhibits migration and invasion and induces mesenchymal-epithelial transition in human breast adenocarcinoma cells. Chen TC; Hsu YL; Tsai YC; Chang YW; Kuo PL; Chen YH J Mol Med (Berl); 2014 Jan; 92(1):53-64. PubMed ID: 24005829 [TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA NKILA inhibits migration and invasion of non-small cell lung cancer via NF-κB/Snail pathway. Lu Z; Li Y; Wang J; Che Y; Sun S; Huang J; Chen Z; He J J Exp Clin Cancer Res; 2017 Apr; 36(1):54. PubMed ID: 28412955 [TBL] [Abstract][Full Text] [Related]
13. LncRNA NKILA suppresses TGF-β-induced epithelial-mesenchymal transition by blocking NF-κB signaling in breast cancer. Wu W; Chen F; Cui X; Yang L; Chen J; Zhao J; Huang D; Liu J; Yang L; Zeng J; Zeng Z; Pan Y; Su F; Cai J; Ying Z; Zhao Q; Song E; Su S Int J Cancer; 2018 Nov; 143(9):2213-2224. PubMed ID: 29761481 [TBL] [Abstract][Full Text] [Related]
14. Magnoflorine inhibits the malignant phenotypes and increases cisplatin sensitivity of osteosarcoma cells via regulating miR-410-3p/HMGB1/NF-κB pathway. Wang Y; Shang G; Wang W; Qiu E; Pei Y; Zhang X Life Sci; 2020 Sep; 256():117967. PubMed ID: 32553931 [TBL] [Abstract][Full Text] [Related]
15. VEGF/NRP-1axis promotes progression of breast cancer via enhancement of epithelial-mesenchymal transition and activation of NF-κB and β-catenin. Luo M; Hou L; Li J; Shao S; Huang S; Meng D; Liu L; Feng L; Xia P; Qin T; Zhao X Cancer Lett; 2016 Apr; 373(1):1-11. PubMed ID: 26805761 [TBL] [Abstract][Full Text] [Related]
16. Roles of Pin1 as a Key Molecule for EMT Induction by Activation of STAT3 and NF-κB in Human Gallbladder Cancer. Nakada S; Kuboki S; Nojima H; Yoshitomi H; Furukawa K; Takayashiki T; Takano S; Miyazaki M; Ohtsuka M Ann Surg Oncol; 2019 Mar; 26(3):907-917. PubMed ID: 30610554 [TBL] [Abstract][Full Text] [Related]
17. 2-Methoxyestradiol inhibits the proliferation and migration and reduces the radioresistance of nasopharyngeal carcinoma CNE-2 stem cells via NF-κB/HIF-1 signaling pathway inactivation and EMT reversal. Wu SL; Li YJ; Liao K; Shi L; Zhang N; Liu S; Hu YY; Li SL; Wang Y Oncol Rep; 2017 Feb; 37(2):793-802. PubMed ID: 28000883 [TBL] [Abstract][Full Text] [Related]
18. Curcumin prevented human autocrine growth hormone (GH) signaling mediated NF-κB activation and miR-183-96-182 cluster stimulated epithelial mesenchymal transition in T47D breast cancer cells. Coker-Gurkan A; Bulut D; Genc R; Arisan ED; Obakan-Yerlikaya P; Palavan-Unsal N Mol Biol Rep; 2019 Feb; 46(1):355-369. PubMed ID: 30467667 [TBL] [Abstract][Full Text] [Related]
19. Icariin-induced inhibition of SIRT6/NF-κB triggers redox mediated apoptosis and enhances anti-tumor immunity in triple-negative breast cancer. Song L; Chen X; Mi L; Liu C; Zhu S; Yang T; Luo X; Zhang Q; Lu H; Liang X Cancer Sci; 2020 Nov; 111(11):4242-4256. PubMed ID: 32926492 [TBL] [Abstract][Full Text] [Related]
20. The MyD88 inhibitor TJ-M2010-2 suppresses proliferation, migration and invasion of breast cancer cells by regulating MyD88/GSK-3β and MyD88/NF-κB signalling pathways. Liu JH; Chen C; Li ZY; Zou ZM; Gao DC; Zhang X; Kuang XW; Sun ZH; Zheng WJ; Zhou P; Sun SR Exp Cell Res; 2020 Sep; 394(2):112157. PubMed ID: 32610185 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]